Use of LP82 to treat hematopoietic disorders

Details Use of LP82 to treat hematopoietic disorders Use of LP82 to treat hematopoietic disorders

2006-09-05

2006-09-05

Kemmerer, Elizabeth (Department: 1647)

Drug, bio-affecting and body treating compositions

Lymphokine

C424S198100, C514S002600, C514S012200, C530S300000, C530S351000, C530S399000

Reexamination Certificate

active

07101539

ABSTRACT:
The present invention relates to a method of using a mammalian gene sequence and polypeptides encoded thereby to treat mammalian hematopoietic disorders. More specifically the present invention relates to methods of using compositions comprising at least one LP82 agonist, LP82 antagonist, LP82 polynucleotide, LP82 polypeptide, and/or LP82 antibody for the prevention and/or treatment of mammalian hematopoietic disorders, including, but not limited to, anemia, leukemia, and hematopoietic conditions caused by bone marrow transplantation or chemo-/radiation therapy.

REFERENCES:
patent: 6576743 (2003-06-01), Conklin et al.
patent: 6610286 (2003-08-01), Thompson et al.
patent: WO 9927103 (1999-06-01), None
patent: WO 00/12708 (2000-03-01), None
Liu et al. Selective enhancement of multipotential hematopoietic progenitors in vitro and in vivo by IL-20. Blood 102(9): 3206-3208, 2003.
Xu et al. Interleukin-20. Int Immunopharmacol 4: 627-633, 2004.
Rich et al. IL-20-a new effector in skin inflammation. Curr Biol 11: R531-R534, 2001.
Quesenberry et al., “Hematopoietic Stem Cells, Progenitor Cells, and Cytokines”, pp. 153-174, Williams Hematology, Sixth Edition, New York: McGraw-Hill, 2001.
Elgert, K. Immunology, understanding the immune system. New York: Wiley-Liss, Inc., 1996, pp. 304, 324-326.
Geisler and Wagner, Zytokinkombinationen für die In-vivo-und Ex-vivo-Expansion hämatopoetischer Progenitorzellen, Acta Med. Austriaca 2000, 27 (Supplement No. 52) :21-24.
Blumberg H. et al. Interleukin 20: discovery, receptor identification, and role in epidermal function.Cell. 104(1) :9-19, Jan. 12, 2001.
Broxmeyer, Hal E., et al., “Regulation of hematopoiesis in a sea of chemokine family members with a plethora of redundant activities”, Experimental Hematology, 1999, pp. 1113-1123, vol. 27, No. 7.
Goldman, Samuel J., “Preclinical Biology of Interleukin 11: A Multifunctional Hematopoietic Cytokine with Potent Thrombopoietic Activity”, Stem Cells, 1995, pp. 462-471, vol. 13.

Affiliated with

Also associated with

Rating

Use of LP82 to treat hematopoietic disorders does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of LP82 to treat hematopoietic disorders, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of LP82 to treat hematopoietic disorders will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3550569